| Acquired factor X and antithrombin III deficiency in a patient with primary amyloidosis and nephrotic syndrome. | |
| | |
MedLine Citation:
|
PMID: 3876596 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A 45-year-old man with primary amyloidosis was initially seen with nephrotic syndrome. Factor X was found to be 5% and antithrombin III (AT III) 45% of normal plasma values. During an 11-month period, despite severe factor X deficiency, the patient did not have any bleeding complications. He developed progressive renal failure and AT III levels increased to normal, at which time he developed severe bleeding complications. These findings suggest a protective role of AT III deficiency against bleeding in a patient with severe factor X deficiency. |
| | |
Authors:
|
M Quitt; E Aghai; M David; R Kohan; Y Ben Ari; P Froom |
Related Documents
:
|
6976126 - Transhepatic embolization in patients with acute variceal hemorrhage. 1995266 - Demonstration of two distinct subsets of gastric varices. observations during a seven-y... 19580686 - Accurate localization of life threatening colonic hemorrhage during nuclear medicine bl... 19508616 - Prevalence of 'deep' rectal varices in patients with cirrhosis: an eus-based study. 6729646 - Unusual presentation of multiple myeloma. a report of 2 cases. 22038566 - A comprehensive study of autonomic dysfunction in the fibromyalgia patients. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Scandinavian journal of haematology Volume: 35 ISSN: 0036-553X ISO Abbreviation: Scand J Haematol Publication Date: 1985 Aug |
Date Detail:
|
Created Date: 1985-11-20 Completed Date: 1985-11-20 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0404507 Medline TA: Scand J Haematol Country: DENMARK |
Other Details:
|
Languages: eng Pagination: 155-7 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amyloidosis
/
complications*,
drug therapy Antithrombin III Deficiency* Biopsy Blood Coagulation Tests Colchicine / therapeutic use Factor X Deficiency / complications* Gastrointestinal Hemorrhage / etiology Humans Hypoprothrombinemias / complications* Kidney / pathology Male Melphalan / therapeutic use Middle Aged Nephrotic Syndrome / complications* Prednisone / therapeutic use Splenectomy / adverse effects |
| Chemical | |
Reg. No./Substance:
|
148-82-3/Melphalan; 53-03-2/Prednisone; 64-86-8/Colchicine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Immunologic subsets in B cell lymphomas defined by surface immunoglobulin isotype and complement rec...
Next Document: Zinc deficiency and blood lymphocyte function with sickle cell disease.